MedPath

PAFP Provider Feedback Trial in Nepal

Not Applicable
Completed
Conditions
Health Behavior
Interventions
Behavioral: Monthly PAFP rates displayed at clinics.
Registration Number
NCT03071029
Lead Sponsor
Marie Stopes International
Brief Summary

A six-month RCT conducted within 36 health centres throughout urban and rural Nepal. The purpose of the RCT is to test the effectiveness of a peer comparison intervention at increasing uptake of long-acting reversible contraceptives (LARCs) as a percentage of PAFP uptake among clients who receive a safe abortion at a Marie Stopes International Nepal. The total sample size will be \~12,000 safe abortion clients. The primary outcome of interest is LARCs among safe abortion clients at Marie Stopes Centres in Nepal. The secondary outcome is to evaluate the impact of behaviorally designed intervention on the service providers' engagement in discussing measures to increase PAFP LARC uptake among women.

Detailed Description

The overall goal of the proposed research project is to increase uptake of long-acting reversible contraceptives (LARCs) among clients who receive a safe abortion at a Marie Stopes International - Nepal (MSI-N)/ Sunaulo Parivar Nepal (SPN) centre using a behaviourally-informed intervention: monthly feedback to service providers comparing their LARC uptake as a percentage of PAFP uptake performance to other centres. The impact of the intervention will be evaluated using a clustered, stepped wedge randomized controlled trial (RCT). The intervention will be implemented and data will be collected regularly from 36 centres over a period of 6 months. The RCT study design is stepped wedge, meaning that all health centres will begin in the control group and will be randomly assigned to begin receiving the treatment in 4 "steps". Each step will be 1 month in duration. The primary outcome of interest is LARC uptake as a percentage of PAFP uptake. The secondary outcome is type of method selected. The intervention consists of a monthly poster that centres will receive which shows service providers the PAFP LARC % performance at their centre as compared to 3 similar centres. The intervention was developed using a behavioral science methodology, including interviews with clients and service providers at 9 health centres and user-testing of the intervention with service providers at 4 health centres. Data used for this study will consist of daily PAFP LARC uptake data that is already being collected and consolidated at centres. The data will be securely shared between centres and the MSI-N central support office in Kathmandu on a weekly basis. Data will be securely shared between MSI-N and ideas monthly. Monitoring will consist of mystery client visits at each centre two times during the study period. At least one interview will be conducted with each service provider through the study period. The investigators will manually check 5% of all medical records to confirm that electronic data is accurate. Service providers will undergo written consent in order that they may choose to participate, or choose not to participate, in the study. Individual clients will be opted in to having their data shared for the purpose of the study. Clients will be notified about data sharing through posters and interactions with service providers and can choose not to have their data shared. All safe abortion clients, aged 18 and older, are eligible to have their data shared. Data from approximately 12,000 safe abortion clients will be required for the study. Strict confidentiality procedures in line with Marie Stopes International's best practices will be put into place to ensure that information made public or otherwise distributed outside the PIs and other key personnel cannot be linked to any individual client records. Results from the study will be published in a report, among other outputs, and the outcomes will be shared within MSI as well as with the wider sexual and reproductive health (SRH) community.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
12000
Inclusion Criteria
  • All women over the age of 18 who receive safe abortion services at the 36 centres are eligible to participate in the study. Women will be opted in to the study.
Exclusion Criteria
  • Women <18

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention (receive data updates)Monthly PAFP rates displayed at clinics.Intervention clinics will receive a monthly poster that centres will receive which informs service providers of the PAFP LARC uptake rate at their centre. This is a step-wedged randomised controlled trial where all the clinics will eventually receive an intervention by the end of the study.
Primary Outcome Measures
NameTimeMethod
Long term reversible contraceptives uptake as a percentage of post-abortion family planning uptake among safe abortion clients within 2 weeks2 weeks post-abortion

The study aims to observe a minimum 4% difference in PAFP LARC rates at two weeks post-abortion between intervention and control participants.

Secondary Outcome Measures
NameTimeMethod
Types of family planning method used after safe abortion procedure2 weeks post abortion

% of participants using different types of family planning methods at two weeks post-abortion, including % using short-acting vs long-acting contraceptives.

Trial Locations

Locations (36)

Marie Stopes Parbat

🇳🇵

Parbat, Dhaulagiri, Nepal

Marie Stopes Gorkha

🇳🇵

Gorkha, Gandaki, Nepal

Marie Stopes Chandrauta

🇳🇵

Kapilbastu, Lumbini, Nepal

Marie Stopes Gongabu

🇳🇵

Kathmandu, Bagati, Nepal

Marie Stopes Satdobato

🇳🇵

Kathmandu, Bagmati, Nepal

Marie Stopes Pyuthan

🇳🇵

Pyuthan, Rapti, Nepal

Marie Stopes Birgunj

🇳🇵

Parsa, Narayani, Nepal

Marie Stopes Chuchchepati

🇳🇵

Kathmandu, Bagati, Nepal

Marie Stopes Putalisadak

🇳🇵

Kathmandu, Bagmati, Nepal

Marie Stopes Surkhet

🇳🇵

Surkhet, Bheri, Nepal

Marie Stopes Itahari

🇳🇵

Sunsari, Koshi, Nepal

Marie Stopes Birtamod

🇳🇵

Jhapa, Mechi, Nepal

Marie Stopes Dang

🇳🇵

Dang, Rapti, Nepal

Marie Stopes Banepa

🇳🇵

Kavre, Bagmati, Nepal

Marie Stopes Kohalpur

🇳🇵

Banke, Bheri, Nepal

Marie Stopes Dumre

🇳🇵

Tanahun, Gandaki, Nepal

Marie Stopes Janakpur

🇳🇵

Dhanusa, Janakpur, Nepal

Marie Stopes Taulihawa

🇳🇵

Kapilbastu, Lumbini, Nepal

Marie Stopes Hetauda

🇳🇵

Makwanpur, Narayani, Nepal

Marie Stopes Lahan

🇳🇵

Siraha, Sagarmatha, Nepal

Marie Stopes Attariya clinic

🇳🇵

Kailali, Seti, Nepal

Marie Stopes Hile

🇳🇵

Dhankuta, Koshi, Nepal

Marie Stopes Biratnagar

🇳🇵

Morang, Koshi, Nepal

Marie Stopes Bhairahawa

🇳🇵

Rupandehi, Lumbini, Nepal

Marie Stopes Nuwakot

🇳🇵

Nuwakot, Bagmati, Nepal

Marie Stopes Bardibas

🇳🇵

Mahottari, Janakpur, Nepal

Marie Stopes Lalbandi

🇳🇵

Sarlahi, Janakpur, Nepal

Marie Stopes Jumla

🇳🇵

Jumla, Karnali, Nepal

Marie Stopes Gulmi

🇳🇵

Gulmi, Lumbini, Nepal

Marie Stopes Butwal

🇳🇵

Rupandehi, Lumbini, Nepal

Marie Stopes Pokhara

🇳🇵

Kaski, Gandaki, Nepal

Marie stopes Arghakhachi

🇳🇵

Arghakhachi, Lumbini, Nepal

Marie Stopes Bardghat

🇳🇵

Nawalparasi, Lumbini, Nepal

Marie Stopes Narayanghat

🇳🇵

Chitwan, Narayani, Nepal

Marie Stopes Dadheldhura

🇳🇵

Dadheldhura, Mahakali, Nepal

Marie Stopes Ilam

🇳🇵

Ilam, Mechi, Nepal

© Copyright 2025. All Rights Reserved by MedPath